NEW YORK – Twist Bioscience reported on Monday morning that revenues for its fiscal fourth quarter 2020 more than doubled year over year.
For the three months ended Sept. 30, 2020, the firm reported revenues of $32.4 million compared to $15.7 million in the year-ago period. It beat analysts' average revenue estimate of $22.7 million.